Teams focused on cell therapy and diagnostics win first and second place at the Building a Biotech Venture Pitch Competition
Myoxa Therapeutics and Specifix Dx win the Building a Biotech Venture Pitch Competition
Myoxa Therapeutics and Specifix Dx win the Building a Biotech Venture Pitch Competition
Partnership to accelerate health innovation commercialization in the Toronto life sciences ecosystem and in Canada
Research grants awarded to products that could impact cancer and rare genetic diseases.
Themes like lessons learned from COVID-19, symbiotic partnerships and access to risk capital emerge in wide-ranging discussion.
The 6th Annual Symposium on Dec. 9 and 10 will feature renowned experts to explore cutting-edge concepts in health research and innovation.